Reducing Ocular Inflammation Following Retinal Surgery

Issue: January 10, 2010

Sponsorship Statement: This continuing education activity is jointly-sponsored by OCULAR SURGERY NEWS^® and Vindico Medical Education. (INSERT LOGOS)

Support Statement: This activity is supported by an educational grant from Alcon Laboratories, Inc. (INSERT LOGOS)

Title: Reducing Ocular Inflammation Following Retinal Surgery

Learning Objectives: At the conclusion of this activity participants should be able to:

Evaluate evidence-based recommendations that reduce the risk of postsurgical inflammation and pain following retinal surgery.
· Discuss the pathogenesis of postsurgical CME and current interventions for treatment and prevention.

Course Chair:
Carmen A. Puliafito, MD, MBA
Retina/Vitreous Section Editor
OCULAR SURGERY NEWS
Dean, Keck School of Medicine
Professor of Ophthalmology and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, California

Faculty:
William F. Mieler, MD
Professor and Vice-Chairman
Department of Ophthalmology
University of Chicago
Chicago, Illinois
Title:Prevention and Management of Ocular Inflammation and Pain following Retinal Surgery

Keith A. Warren, MD
Clinical Professor
Dept of Ophthalmology
University of Kansas
Founder, Warren Retina Associates
Kansas City, Kansas
Title: Current Concepts in the Prophylaxis and Treatment of Post-surgical CME

Continuing Medical Education Information:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of OCULAR SURGERY NEWS® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit ^tm. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, MONTH XX, 2011 to MONTH XX, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the Pretest questions, watch and listen to the presentations, complete the Posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the Post-test questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Post test is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)^tm certificate.

Faculty:
Carmen A. Puliafito, MD, MBA
William F. Mieler, MD
Keith A. Warren, MD

Peer Reviewer:
William Lloyd, MD

Disclosures: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page. The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support. Faculty members report the following relationship(s):

Carmen A. Puliafito, MD, MBA
Consultant: Zeiss Meditec

William F. Mieler, MD
Consulting Fees: Alcon Laboratories, Inc., Allergan, Genentech

Keith A. Warren, MD
Consulting Fees: Alcon Laboratories, Inc, DORC, Genentech
Fees for Non-CME Services: Alcon Laboratories, Inc, DORC, Genentech

Peer reviewer reports the following relationship(s):
William Lloyd, MD (an employee of Vindico Medical Education)
No relevant financial relationships to disclose.

Vindico Medical Education and OCULAR SURGERY NEWS ^® staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Overview:

Target Audience: The intended learners for this activity are vitreoretinal specialists, comprehensive ophthalmologists, and other healthcare professionals involved in the treatment of patients with vitreoretinal disorders.

Unlabeled and Investigational Usage: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement: Created and published by Slack Incorpoated^®, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright^© 2011 Slack Incorporated^®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and OCULAR SURGERY NEWS^® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and OCULAR SURGERY NEWS^®. Neither Vindico Medical Education, OCULAR SURGERY NEWS^®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.